3-Oxo-3-(4-(pyrrolidin-1-yl)phenyl)propanenitrile

Catalog No. :
ACAVSF790
CAS No. :
887595-01-9
Molecular Formula :
C13H14N2O
Molecular Weight :
214.27

IUPAC Name:3-oxo-3-(4-(pyrrolidin-1-yl)phenyl)propanenitrile

3-Oxo-3-(4-(pyrrolidin-1-yl)phenyl)propanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$368.00Login to see priceInquiryInquiry
250mg95%$465.00Login to see priceInquiryInquiry
1g95%$604.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Oxo-3-(4-(pyrrolidin-1-yl)phenyl)propanenitrile
IUPAC Name3-oxo-3-(4-(pyrrolidin-1-yl)phenyl)propanenitrile
MDL No.MFCD07786223
Molecular FormulaC13H14N2O
Molecular Weight214.27
SMILESN#CCC(C1=CC=C(N2CCCC2)C=C1)=O
InChI KeyMQEWNXVQQGJDKO-UHFFFAOYSA-N
Synonym3-OXO-3-(4-PYRROLIDIN-1-YL-PHENYL)-PROPIONITRILE;3-Oxo-3-[4-(1-pyrrolidinyl)phenyl]propanenitrile;3-Oxo-3-(4-(pyrrolidin-1-yl)phenyl)propanenitrile;Benzenepropanenitrile, β-oxo-4-(1-pyrrolidinyl)-
CAS No.887595-01-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAVSF790 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRIYT325 route compound structure diagram
    ACRIYT3254640-67-9 In Stock
  4. Then
  5. ACAVSF790 route product structure diagram
    ACAVSF790887595-01-9
Inquiry

2. ACAVSF790 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACURGJ723 route compound structure diagram
    ACURGJ7234592-94-3 In Stock
  4. Then
  5. ACAVSF790 route product structure diagram
    ACAVSF790887595-01-9
Inquiry

Comments (0)